Internal Medicine, Medical Oncology · Albuquerque, NM
NPI
1346234788
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4901 Lang Ave NE, New Mexico Oncology & Hematology Consultants, Ltd
Albuquerque, NM, 87109
Phone (505) 842-8171
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
96,870 services
Medicare patients, 2024
676
Average age 74
Drug cost, 2024
$4.2M
1,628 prescriptions
Company payments, 2025
$26K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Annette C Fontaine was code Q5101 (injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram), 8,640 times for 11 patients. In total Annette C Fontaine billed 96,870 services in 173 codes, and Medicare paid $1.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 8,640 | 11 | $0.23 | $2,022 |
| J0897 Injection, denosumab, 1 mg | Office | 5,580 | 34 | $20.52 | $114K |
| J0185 Injection, aprepitant, 1 mg | Office | 4,420 | 17 | $1.34 | $5,923 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 3,400 | 12 | $44.54 | $151K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,930 | 58 | $0.09 | $173 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,340 | 46 | $0.75 | $1,001 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 512 | 12 | $3.54 | $1,813 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 508 | 340 | $12.00 | $6,094 |
| 99215 Office E&M - Established | Office | 461 | 200 | $128.13 | $59K |
| J9190 Injection, fluorouracil, 500 mg | Office | 302 | 12 | $2.39 | $721 |
| 96367 Intravenous Infusion, Hydration | Office | 269 | 67 | $20.76 | $5,583 |
| 99214 Office E&M - Established | Office | 244 | 199 | $86.15 | $21K |
| 96413 Chemotherapy Administration | Office | 201 | 88 | $93.60 | $19K |
| 96375 Injection Administration | Office | 196 | 60 | $11.16 | $2,187 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 190 | 11 | $0.24 | $46.07 |
By year: 2022 $2.3M for 116,681 services; 2023 $2.2M for 132,564 services; 2024 $1.4M for 96,870 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 113 | 80 | $8.58 | $969 |
Medicare prescription drug claims, 2024
In 2024, the drug Annette C Fontaine prescribed most often to Medicare patients was Anastrozole, with 98 prescriptions and refills. In total Annette C Fontaine wrote 1,628 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 98 | 286 | 37 | $2,855 |
| Gabapentin Generic | 94 | 137 | 22 | $830 |
| Letrozole Generic | 91 | 244 | 24 | $2,039 |
| Acyclovir Generic | 73 | 101 | 24 | $926 |
| Xarelto Rivaroxaban | 68 | 117 | 18 | $62K |
| Tamoxifen Citrate Generic | 64 | 182 | 20 | $1,728 |
| Ibrance Palbociclib | 51 | 51 | Under 11 | $802K |
| Exemestane Generic | 46 | 83 | 12 | $3,422 |
| Hydroxyurea Generic | 44 | 101 | Under 11 | $1,021 |
| Levothyroxine Sodium Generic | 40 | 78 | 18 | $386 |
| Ondansetron Odt Ondansetron | 36 | 37 | 29 | $732 |
| Alendronate Sodium Generic | 35 | 55 | Under 11 | $262 |
| Eliquis Apixaban | 33 | 39 | Under 11 | $23K |
| Jakafi Ruxolitinib Phosphate | 33 | 33 | Under 11 | $585K |
| Raloxifene Hcl Generic | 32 | 59 | Under 11 | $789 |
Brand drugs: - claims; generic drugs: 1,199 claims; opioid claims: 57.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Annette C Fontaine $26K ($26K in general payments such as food, travel and fees) from 10 companies. The largest payer was Daiichi Sankyo Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 19 | $17K |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $5,250 |
| Stemline Therapeutics Inc. | 2 | $2,581 |
| Gilead Sciences, Inc. GILD | 1 | $450 |
| Janssen Biotech, Inc. JNJ | 2 | $54.91 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $49.78 |
| Incyte Corporation INCY | 1 | $28.64 |
| Servier Pharmaceuticals LLC | 1 | $21.02 |
| Abbvie Inc. ABBV | 1 | $19.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.